Essential phospholipids as a supportive adjunct in the management of patients with NAFLD
Arab Journal of Gastroenterology. 2015; 16 (3-4): 99-104
en Inglés
| IMEMR
| ID: emr-174961
ABSTRACT
Background and study aims:
Treatment of nonalcoholic fatty liver [NAFLD] is important because NAFLD patients have a 1.7-fold increase in standardised age and gender matched mortality. Currently treatment is based on life style modification and managing comorbid associating disease. Other medications remain experimental. Essential phospholipid [EPL] is a nutrient for the liver, helping to maintain vitality of cell membranes where the vast majority of liver activities are regulated. We performed a randomised open label study to evaluate EPL as an adjuvant nutrient to the treatment of primary NAFLD or NAFLD with comorbid disease
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Fosfatidilcolinas
/
Fosfolípidos
/
Estudios Prospectivos
/
Manejo de la Enfermedad
/
Transaminasas
Límite:
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Arab J. Gastroenterol.
Año:
2015
Similares
MEDLINE
...
LILACS
LIS